OQROSign up free
5%+ stake, activist

Aeon Biopharma (AEON): Daewoong Co., Ltd. disclosed a 30.6% stake in AEON and may seek to influence the company 30.6%

Daewoong Co., Ltd. disclosed a 30.6% stake in AEON and may seek to influence the company.

30.6%
Stake
23.2M
Shares owned
Stake as of
Oct 30, 2026
Filed
Nov 10, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Nov 2, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
    2. Nov 10, 20265% stakeDaewoong Co., Ltd. filed an activist stake (13D) of 30.6%
    3. Nov 13, 20265% stakeNantahala Capital Management, LLC reported a passive stake (13G) of 10.0%
    View the official recordSEC Schedule 13D

    How to read SEC Schedule 13D

    A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.

    Full guide: Schedule 13D vs Schedule 13G: what is the difference?

    What else is on file for Aeon Biopharma

    For Aeon Biopharma, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AEON page.

    How this filing works

    Explore the data

    Common questions

    What does this filing report about Aeon Biopharma (AEON) stock?

    Daewoong Co., Ltd. disclosed a 30.6% stake in AEON and may seek to influence the company. Of the company, Schedule 13D (may seek influence).

    When did it happen, and when was it made public?

    Stake as of: Oct 30, 2026. Filed: Nov 10, 2026.

    Is this a trade made on a known date?

    No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

    Where does this information come from?

    From the SEC Schedule 13D, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

    What else has been disclosed about Aeon Biopharma recently?

    For Aeon Biopharma, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the AEON page.

    Does this mean AEON stock is a buy or a sell?

    No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

    Is OQRO free?

    Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

    Other disclosures at Aeon Biopharma

    Everything OQRO holds on this company is on its AEON page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    Sign up freeAlready have an account? Log in

    OQRO is free for everyone. No card, no trial

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data